Fullscript and ŌURA partner to bring wearable data into clinical workflows
Fullscript has partnered with wearable device company ŌURA to bring its biometric insights into Fullscript's clinical workflows, the company announced Monday at the J.P. Morgan Healthcare Conference in San Francisco.
Headquartered in Ottawa, Ontario, Fullscript offers a suite of clinical tools to help providers deliver whole-person care, including diagnostics, clinical decision support, supplementation and more. It has served more than 125,000 healthcare providers and 10 million patients.
Meanwhile, Finland-based ŌURA offers a wearable smart ring called the Oura Ring, along with an accompanying app. The ring provides personalized insights and guidance on sleep, activity, readiness, stress, resiliency, women's health and heart health.
Through this partnership, providers using Fullscript will be able to view patient sleep, readiness and activity data from ŌURA if the patient opts in. This information will be provided along with medical history and laboratory diagnosis. Patients can also view ŌURA's biometric trends, refill regimens and lab results in one system through Fullscript.
“Continuous, longitudinal health signals, like those captured with the Oura Ring, are most powerful when they are tied to real clinical decisions,” Dr. Ricky Bloomfield, Oura's chief medical officer, said in a statement. “By integrating Oura insights into Fullscript, we’re giving providers a deeper understanding of how their patients are sleeping, recovering and coping with daily stress so they can spend less time piecing together data and more time delivering proactive, preventive care that benefits individuals, clinicians and health systems alike.”
The partnership will begin rolling out in early 2026. In the second quarter, Oura rings will also be available to order on the Fullscript catalog, allowing providers to begin recommending these rings to patients.
This is Fullscript's first collaboration with a wearables company, and Fullscript says ŌURA was a natural starting point. The collaboration makes it easier for providers to adjust care plans.
“I have patients who are wearing the Oura ring and they hand me their phone when they come in,” Dr. Jeffrey Gladd, Fullscript's chief medical officer, said in an interview. “Well, me looping through their last 90 days of data doesn't really provide a lot of insight, and now in Fullscript we'll be able to understand that. I can make recommendations or adjustments to the plan immediately.”
Fullscript President and Chief Financial Officer Ashley Koch echoed these comments.
“Our vision at Fullscript is basically … to take what consumers are doing, what their habits are, what their normal patterns are, how they are using digital health applications in a consumer setting, and marry that with providers' clinical workflows so that we can unify treatment plans so that we can monitor patients over time so that we can provide providers with better insights that are more actionable,” she said.
Image source: PeopleImages, Getty Images
